The Effect on Bone Outcomes of Home-based Exercise Intervention for Prostate Cancer Survivors Receiving Androgen Deprivation Therapy: A Pilot Randomized Controlled Trial

Cancer Nurs. 2018 Sep/Oct;41(5):379-388. doi: 10.1097/NCC.0000000000000530.

Abstract

Background: Cancer treatment-induced bone loss has important long-term effects in prostate cancer survivors (PCSs) receiving androgen deprivation therapy (ADT), but little is known about preventive interventions.

Objective: The aim of this study was to examine the feasibility and preliminary effectiveness of a 6-month home-based exercise intervention in PCSs.

Methods: In this pilot, randomized controlled trial, 51 men (mean age, 70.8 years) were randomized to a 6-month home-based exercise intervention for preventing osteoporosis group (n = 26) or an exercise placebo intervention of stretching exercise group (n = 25). Primary outcomes were bone mineral density and bone turnover markers. Secondary outcomes were physical performance (level of physical activity, muscle strength, and balance) and health-related quality of life.

Results: The patient retention rate for 6 months was 80.4%. The mean adherence rate was 84.7% for weight-bearing exercise and 64.8% for resistance exercise. No adverse events during the study period were reported. Although primary outcomes did not differ significantly between the 2 groups, the home-based exercise intervention for preventing osteoporosis group demonstrated significantly greater increased muscle strength than the stretching exercise group.

Conclusions: A home-based exercise program is relatively feasible and safe and may improve muscle strength but not bone outcomes.

Implications for practice: Given the importance of preventing cancer treatment-induced bone loss among PCSs receiving ADT, a home-based exercise intervention can be considered, but further trials with a larger sample are required to determine its effect for bone outcomes.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Androgen Antagonists / therapeutic use*
  • Bone Density / drug effects*
  • Bone Diseases, Metabolic / prevention & control
  • Cancer Survivors / psychology*
  • Exercise Therapy / methods*
  • Humans
  • Male
  • Middle Aged
  • Muscle Strength / drug effects*
  • Pilot Projects
  • Prostatic Neoplasms / drug therapy*
  • Quality of Life / psychology*

Substances

  • Androgen Antagonists